Tongling Jieya Biologic Technology Co Ltd is a China-based company mainly engaged in the production of wipes. The Company's main businesses are the research and development, production and sales of sanitary products. The Company's wet wipes products include baby series, adult functional series, antibacterial disinfection series, household cleaning series, medical care series and pet cleaning series. The Company is also engaged in the production of facial masks.

Employees

618

Sector

Personal Products

Calendar

Aug. 26 - Q2 2025 Earnings Release (Projected)

More about the company

Quotes

Date	Price	Change	Volume
25-06-23	32.58 ¥	+2.13%	1,204,720
25-06-20	31.90 ¥	-0.93%	1,155,511
25-06-19	32.20 ¥	-2.72%	1,856,991
25-06-18	33.10 ¥	-6.76%	3,408,632
25-06-17	35.50 ¥	-4.54%	2,948,971

End-of-day quote Shenzhen S.E., June 22, 2025

More quotes

Income Statement and Estimates

More financial data

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

End-of-day quote Shenzhen S.E. Other stock markets 2025-06-23			5-day change	1st Jan Change
32.58 ^CNY	+2.13%		-12.40%	+26.52%

Apr. 24	Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
Apr. 24	Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	CI

Capitalization	2.62B 365M 316M 296M 270M 501M 31.59B 567M 3.51B 1.35B 14.49B 1.37B 1.34B 53.4B	P/E ratio 2025 *	16.8x	P/E ratio 2026 *	15.2x
Enterprise value	2.62B 365M 316M 296M 270M 501M 31.59B 567M 3.51B 1.35B 14.49B 1.37B 1.34B 53.4B	EV / Sales 2025 *	3.17x	EV / Sales 2026 *	-
Free-Float	29.37%	Yield 2025 *	1.5%	Yield 2026 *	-

Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	Apr. 24	CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	Apr. 24	CI
Certain A Shares of Tongling Jieya Biologic Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 4-DEC-2024.	Dec. 03	CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	24-10-29	CI
Tranche Update on Tongling Jieya Biologic Technology Co., Ltd.'s Equity Buyback Plan announced on April 11, 2024.	24-09-04	CI
Tongling Jieya Biologic Technology Co., Ltd.'s Equity Buyback announced on April 11, 2024, has closed with 812,495 shares, representing 1% for CNY 20.05 million.	24-09-02	CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	24-08-27	CI
Tranche Update on Tongling Jieya Biologic Technology Co., Ltd.'s Equity Buyback Plan announced on April 11, 2024.	24-07-01	CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	24-04-25	CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	24-04-15	CI
Tongling Jieya Biologic Technology Co., Ltd. commences an Equity Buyback Plan for CNY 40 million worth of its shares, under the authorization approved on March 13, 2024.	24-04-10	CI
Certain A Shares of Tongling Jieya Biologic Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 4-DEC-2023.	23-12-03	CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-29	CI

1 day	+2.13%
1 week	-12.40%
Current month	+3.72%
1 month	-6.11%
3 months	+20.62%
6 months	+25.55%
Current year	+26.52%

Tongling Jieya Biologic Technology Co., Ltd. Stock

Equities

301108

CNE1000054S9

Personal Products

Valuation: Tongling Jieya Biologic Technology Co., Ltd.

Chart: Tongling Jieya Biologic Technology Co., Ltd.

Latest news: Tongling Jieya Biologic Technology Co., Ltd.

Quotes and Performance

Course Extremes

Managers and Directors: Tongling Jieya Biologic Technology Co., Ltd.

Sanitary Products

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

1 week	31.46	35
1 month	31.17	41.26
Current year	21.31	41.26
1 year	20.81	41.26
3 years	20.81	42.21
5 years	20.81	97.58
10 years	20.81	97.58

Manager	Title	Age	Since
Ying Chuan Cai CEO	Chief Executive Officer	55	2014-02-28
Yun Feng Lu ADM	Chief Administrative Officer	42	2018-07-31
Fan Long Yang DFI	Director of Finance/CFO	37	2020-01-31

Director	Title	Age	Since
Ying Chuan Cai CHM	Chairman	55	2008-12-23
Yan Feng BRD	Director/Board Member	51	2008-12-23
Ying Ye BRD	Director/Board Member	48	2016-04-30

	2025 *	2026 *
Net sales	825M 115M 99.55M 93.37M 85.1M 158M 9.95B 178M 1.11B 426M 4.56B 431M 422M 16.82B	-
Net income	157M 21.87M 18.94M 17.77M 16.2M 30.02M 1.89B 33.97M 211M 81M 869M 82.05M 80.3M 3.2B	-
Net Debt	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
TONGLING JIEYA BIOLOGIC TECHNOLOGY CO., LTD.	+2.13%	-12.40%	+30.01%	-17.73%	365M
KIMBERLY-CLARK CORPORATION	+1.43%	-0.41%	-6.70%	-1.48%	43.18B
UNICHARM CORPORATION	+0.75%	-4.77%	-38.37%	-30.33%	12.8B
GILLETTE INDIA LIMITED	+2.35%	-1.59%	+37.52%	+106.35%	3.77B
HENGAN INTERNATIONAL GROUP COMPANY LIMITED	+2.54%	+0.91%	-7.69%	-37.90%	3.2B
CHONGQING BAIYA SANITARY PRODUCTS CO., LTD.	-0.04%	-5.29%	+10.19%	+117.34%	1.55B
HANGZHOU HAOYUE PERSONAL CARE CO., LTD	+0.96%	-8.22%	+53.39%	+63.05%	1.31B
C&S PAPER CO.,LTD	+0.15%	-3.39%	-6.55%	-44.17%	1.18B
OIL-DRI CORPORATION OF AMERICA	+4.68%	+5.45%	+91.23%	+305.56%	875M
LAFANG CHINA CO.,LTD	-0.09%	-6.42%	+107.58%	+60.20%	697M
Average	+1.45%	-3.27%	+27.06%	+52.09%	6.89B
Weighted average by Cap.	+1.16%	-2.63%	-6.08%	+4.98%